APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurovascular Interventional Devices

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Neurovascular Interventional Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026191 pages

Choose your research edition.

Industry ResearchNeurovascular Interventional Devices Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurovascular Interventional Devices Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Neurovascular Interventional Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurovascular Interventional Devices Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurovascular Interventional Devices Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Neurovascular Interventional Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Neurovascular Interventional Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Neurovascular Interventional Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neurovascular Interventional Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Neurovascular Interventional Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Neurovascular Interventional Devices include Johnson & Johnson, Medtronic PLC, W.L. Gore & Associates, Terumo Corporation, Stryker Corporation, Penumbra, Inc., Microport Scientific Corporation, Merit Medical Systems, Inc. and Cardinal Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Neurovascular Interventional Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neurovascular Interventional Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neurovascular Interventional Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neurovascular Interventional Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Neurovascular Interventional Devices Segment by Company

Johnson & Johnson

Medtronic PLC

W.L. Gore & Associates

Terumo Corporation

Stryker Corporation

Penumbra, Inc.

Microport Scientific Corporation

Merit Medical Systems, Inc.

Cardinal Health

Boston Scientific Corporation

Abbott Laboratories

Neurovascular Interventional Devices Segment by Type

Embolization Coils

Intrasaccular Devices

Intracranial Stents

Carotid Stents

Flow Diverters

Others

Neurovascular Interventional Devices Segment by Application

Ambulatory Surgical Centers

Hospitals

Clinics

Others

Neurovascular Interventional Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurovascular Interventional Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurovascular Interventional Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurovascular Interventional Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neurovascular Interventional Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neurovascular Interventional Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Neurovascular Interventional Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Neurovascular Interventional Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Neurovascular Interventional Devices Industry Trends Table 2. Neurovascular Interventional Devices Industry Drivers Table 3. Neurovascular Interventional Devices Industry Opportunities and Challenges Table 4. Neurovascular Interventional Devices Industry Restraints Table 5. Global Neurovascular Interventional Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Neurovascular Interventional Devices Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Neurovascular Interventional Devices Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Neurovascular Interventional Devices Sales Market Share by Manufacturers Table 9. Global Neurovascular Interventional Devices Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Neurovascular Interventional Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Neurovascular Interventional Devices Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Neurovascular Interventional Devices Manufacturers, Product Type & Application Table 13. Global Neurovascular Interventional Devices Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Neurovascular Interventional Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Embolization Coils Table 17. Major Manufacturers of Intrasaccular Devices Table 18. Major Manufacturers of Intracranial Stents Table 19. Major Manufacturers of Carotid Stents Table 20. Major Manufacturers of Flow Diverters Table 21. Major Manufacturers of Others Table 22. Global Neurovascular Interventional Devices Sales by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Neurovascular Interventional Devices Sales by Type (2021-2026) & (k units) Table 24. Global Neurovascular Interventional Devices Sales by Type (2027-2032) & (k units) Table 25. Global Neurovascular Interventional Devices Sales Market Share by Type (2021-2026) Table 26. Global Neurovascular Interventional Devices Sales Market Share by Type (2027-2032) Table 27. Global Neurovascular Interventional Devices Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 28. Global Neurovascular Interventional Devices Revenue by Type (2021-2026) & (k units) Table 29. Global Neurovascular Interventional Devices Revenue by Type (2027-2032) & (k units) Table 30. Global Neurovascular Interventional Devices Revenue Market Share by Type (2021-2026) Table 31. Global Neurovascular Interventional Devices Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Ambulatory Surgical Centers Table 33. Major Manufacturers of Hospitals Table 34. Major Manufacturers of Clinics Table 35. Major Manufacturers of Others Table 36. Global Neurovascular Interventional Devices Sales by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Neurovascular Interventional Devices Sales by Application (2021-2026) & (k units) Table 38. Global Neurovascular Interventional Devices Sales by Application (2027-2032) & (k units) Table 39. Global Neurovascular Interventional Devices Sales Market Share by Application (2021-2026) Table 40. Global Neurovascular Interventional Devices Sales Market Share by Application (2027-2032) Table 41. Global Neurovascular Interventional Devices Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 42. Global Neurovascular Interventional Devices Revenue by Application (2021-2026) & (k units) Table 43. Global Neurovascular Interventional Devices Revenue by Application (2027-2032) & (k units) Table 44. Global Neurovascular Interventional Devices Revenue Market Share by Application (2021-2026) Table 45. Global Neurovascular Interventional Devices Revenue Market Share by Application (2027-2032) Table 46. Global Neurovascular Interventional Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global Neurovascular Interventional Devices Sales by Region (2021-2026) & (k units) Table 48. Global Neurovascular Interventional Devices Sales Market Share by Region (2021-2026) Table 49. Global Neurovascular Interventional Devices Sales Forecasted by Region (2027-2032) & (k units) Table 50. Global Neurovascular Interventional Devices Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Neurovascular Interventional Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. North America Neurovascular Interventional Devices Sales by Country (2021-2026) & (k units) Table 53. North America Neurovascular Interventional Devices Sales by Country (2027-2032) & (k units) Table 54. Europe Neurovascular Interventional Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Europe Neurovascular Interventional Devices Sales by Country (2021-2026) & (k units) Table 56. Europe Neurovascular Interventional Devices Sales by Country (2027-2032) & (k units) Table 57. Asia Pacific Neurovascular Interventional Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Asia Pacific Neurovascular Interventional Devices Sales by Country (2021-2026) & (k units) Table 59. Asia Pacific Neurovascular Interventional Devices Sales by Country (2027-2032) & (k units) Table 60. South America, Middle East and Africa Neurovascular Interventional Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 61. South America, Middle East and Africa Neurovascular Interventional Devices Sales by Country (2021-2026) & (k units) Table 62. South America, Middle East and Africa Neurovascular Interventional Devices Sales by Country (2027-2032) & (k units) Table 63. Global Neurovascular Interventional Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Neurovascular Interventional Devices Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Neurovascular Interventional Devices Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Neurovascular Interventional Devices Revenue Market Share by Region (2021-2026) Table 67. Global Neurovascular Interventional Devices Revenue Market Share by Region (2027-2032) Table 68. Johnson & Johnson Company Information Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Neurovascular Interventional Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Johnson & Johnson Neurovascular Interventional Devices Product Portfolio Table 72. Johnson & Johnson Recent Development Table 73. Medtronic PLC Company Information Table 74. Medtronic PLC Business Overview Table 75. Medtronic PLC Neurovascular Interventional Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Medtronic PLC Neurovascular Interventional Devices Product Portfolio Table 77. Medtronic PLC Recent Development Table 78. W.L. Gore & Associates Company Information Table 79. W.L. Gore & Associates Business Overview Table 80. W.L. Gore & Associates Neurovascular Interventional Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. W.L. Gore & Associates Neurovascular Interventional Devices Product Portfolio Table 82. W.L. Gore & Associates Recent Development Table 83. Terumo Corporation Company Information Table 84. Terumo Corporation Business Overview Table 85. Terumo Corporation Neurovascular Interventional Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Terumo Corporation Neurovascular Interventional Devices Product Portfolio Table 87. Terumo Corporation Recent Development Table 88. Stryker Corporation Company Information Table 89. Stryker Corporation Business Overview Table 90. Stryker Corporation Neurovascular Interventional Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Stryker Corporation Neurovascular Interventional Devices Product Portfolio Table 92. Stryker Corporation Recent Development Table 93. Penumbra, Inc. Company Information Table 94. Penumbra, Inc. Business Overview Table 95. Penumbra, Inc. Neurovascular Interventional Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Penumbra, Inc. Neurovascular Interventional Devices Product Portfolio Table 97. Penumbra, Inc. Recent Development Table 98. Microport Scientific Corporation Company Information Table 99. Microport Scientific Corporation Business Overview Table 100. Microport Scientific Corporation Neurovascular Interventional Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Microport Scientific Corporation Neurovascular Interventional Devices Product Portfolio Table 102. Microport Scientific Corporation Recent Development Table 103. Merit Medical Systems, Inc. Company Information Table 104. Merit Medical Systems, Inc. Business Overview Table 105. Merit Medical Systems, Inc. Neurovascular Interventional Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Merit Medical Systems, Inc. Neurovascular Interventional Devices Product Portfolio Table 107. Merit Medical Systems, Inc. Recent Development Table 108. Cardinal Health Company Information Table 109. Cardinal Health Business Overview Table 110. Cardinal Health Neurovascular Interventional Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Cardinal Health Neurovascular Interventional Devices Product Portfolio Table 112. Cardinal Health Recent Development Table 113. Boston Scientific Corporation Company Information Table 114. Boston Scientific Corporation Business Overview Table 115. Boston Scientific Corporation Neurovascular Interventional Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Boston Scientific Corporation Neurovascular Interventional Devices Product Portfolio Table 117. Boston Scientific Corporation Recent Development Table 118. Abbott Laboratories Company Information Table 119. Abbott Laboratories Business Overview Table 120. Abbott Laboratories Neurovascular Interventional Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Abbott Laboratories Neurovascular Interventional Devices Product Portfolio Table 122. Abbott Laboratories Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Neurovascular Interventional Devices Distributors List Table 126. Neurovascular Interventional Devices Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Neurovascular Interventional Devices Product Image Figure 2. Global Neurovascular Interventional Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurovascular Interventional Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Neurovascular Interventional Devices Sales (2021-2032) & (k units) Figure 5. Global Neurovascular Interventional Devices Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Neurovascular Interventional Devices Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Embolization Coils Image Figure 9. Intrasaccular Devices Image Figure 10. Intracranial Stents Image Figure 11. Carotid Stents Image Figure 12. Flow Diverters Image Figure 13. Others Image Figure 14. Global Neurovascular Interventional Devices Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Neurovascular Interventional Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Neurovascular Interventional Devices Sales Market Share by Type (2021-2032) Figure 17. Global Neurovascular Interventional Devices Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 18. Global Neurovascular Interventional Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Neurovascular Interventional Devices Revenue Market Share by Type (2021-2032) Figure 20. Ambulatory Surgical Centers Image Figure 21. Hospitals Image Figure 22. Clinics Image Figure 23. Others Image Figure 24. Global Neurovascular Interventional Devices Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Neurovascular Interventional Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Neurovascular Interventional Devices Sales Market Share by Application (2021-2032) Figure 27. Global Neurovascular Interventional Devices Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 28. Global Neurovascular Interventional Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Neurovascular Interventional Devices Revenue Market Share by Application (2021-2032) Figure 30. North America Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 31. North America Neurovascular Interventional Devices Sales Market Share by Country (2021-2032) Figure 32. U.S. Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 33. Canada Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 34. Mexico Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 36. Europe Neurovascular Interventional Devices Sales Market Share by Country (2021-2032) Figure 37. Germany Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 38. France Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 39. U.K. Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 40. Italy Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 41. Netherlands Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 43. Asia Pacific Neurovascular Interventional Devices Sales Market Share by Country (2021-2032) Figure 44. China Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 45. Japan Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 46. South Korea Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 47. Southeast Asia Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 48. India Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 49. Australia Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 51. South America, Middle East and Africa Neurovascular Interventional Devices Sales Market Share by Country (2021-2032) Figure 52. Brazil Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 53. South Africa Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 54. Saudi Arabia Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 55. Turkey Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 56. Argentina Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 57. UAE Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 58. Egypt Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 59. Chile Neurovascular Interventional Devices Sales and Growth Rate (2021-2032) & (k units) Figure 60. Global Neurovascular Interventional Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Neurovascular Interventional Devices Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Figure 63. North America Neurovascular Interventional Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Figure 65. Europe Neurovascular Interventional Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Neurovascular Interventional Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Neurovascular Interventional Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Neurovascular Interventional Devices Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Neurovascular Interventional Devices Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Embolization Coils
  • Intrasaccular Devices
  • Intracranial Stents
  • Carotid Stents
  • Flow Diverters
  • Others
Applications
  • Ambulatory Surgical Centers
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Johnson & Johnson
  • Medtronic PLC
  • W.L. Gore & Associates
  • Terumo Corporation
  • Stryker Corporation
  • Penumbra, Inc.
  • Microport Scientific Corporation
  • Merit Medical Systems, Inc.
  • Cardinal Health
  • Boston Scientific Corporation
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Neurovascular Interventional Devices Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Neurovascular Interventional Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Neurovascular Interventional Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Neurovascular Interventional Devices Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Neurovascular Interventional Devices Market Dynamics
  1. 2.1 Neurovascular Interventional Devices Industry Trends
  2. 2.2 Neurovascular Interventional Devices Industry Drivers
  3. 2.3 Neurovascular Interventional Devices Industry Opportunities and Challenges
  4. 2.4 Neurovascular Interventional Devices Industry Restraints
3 Neurovascular Interventional Devices Market by Manufacturers
  1. 3.1 Global Neurovascular Interventional Devices Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Neurovascular Interventional Devices Sales by Manufacturers (2021-2026)
  3. 3.3 Global Neurovascular Interventional Devices Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Neurovascular Interventional Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neurovascular Interventional Devices Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Neurovascular Interventional Devices Manufacturers, Product Type & Application
  7. 3.7 Global Neurovascular Interventional Devices Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neurovascular Interventional Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neurovascular Interventional Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neurovascular Interventional Devices Tier 1, Tier 2, and Tier 3
4 Neurovascular Interventional Devices Market by Type
  1. 4.1 Neurovascular Interventional Devices Type Introduction
  2. 4.1.1 Embolization Coils
  3. 4.1.2 Intrasaccular Devices
  4. 4.1.3 Intracranial Stents
  5. 4.1.4 Carotid Stents
  6. 4.1.5 Flow Diverters
  7. 4.1.6 Others
  8. 4.2 Global Neurovascular Interventional Devices Sales by Type
  9. 4.2.1 Global Neurovascular Interventional Devices Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Neurovascular Interventional Devices Sales by Type (2021-2032)
  11. 4.2.3 Global Neurovascular Interventional Devices Sales Market Share by Type (2021-2032)
  12. 4.3 Global Neurovascular Interventional Devices Revenue by Type
  13. 4.3.1 Global Neurovascular Interventional Devices Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Neurovascular Interventional Devices Revenue by Type (2021-2032)
  15. 4.3.3 Global Neurovascular Interventional Devices Revenue Market Share by Type (2021-2032)
5 Neurovascular Interventional Devices Market by Application
  1. 5.1 Neurovascular Interventional Devices Application Introduction
  2. 5.1.1 Ambulatory Surgical Centers
  3. 5.1.2 Hospitals
  4. 5.1.3 Clinics
  5. 5.1.4 Others
  6. 5.2 Global Neurovascular Interventional Devices Sales by Application
  7. 5.2.1 Global Neurovascular Interventional Devices Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Neurovascular Interventional Devices Sales by Application (2021-2032)
  9. 5.2.3 Global Neurovascular Interventional Devices Sales Market Share by Application (2021-2032)
  10. 5.3 Global Neurovascular Interventional Devices Revenue by Application
  11. 5.3.1 Global Neurovascular Interventional Devices Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Neurovascular Interventional Devices Revenue by Application (2021-2032)
  13. 5.3.3 Global Neurovascular Interventional Devices Revenue Market Share by Application (2021-2032)
6 Global Neurovascular Interventional Devices Sales by Region
  1. 6.1 Global Neurovascular Interventional Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neurovascular Interventional Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Neurovascular Interventional Devices Sales by Region (2021-2026)
  4. 6.2.2 Global Neurovascular Interventional Devices Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Neurovascular Interventional Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Neurovascular Interventional Devices Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Neurovascular Interventional Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Neurovascular Interventional Devices Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Neurovascular Interventional Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Neurovascular Interventional Devices Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Neurovascular Interventional Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Neurovascular Interventional Devices Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Neurovascular Interventional Devices Revenue by Region
  1. 7.1 Global Neurovascular Interventional Devices Revenue by Region
  2. 7.1.1 Global Neurovascular Interventional Devices Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Neurovascular Interventional Devices Revenue by Region (2021-2026)
  4. 7.1.3 Global Neurovascular Interventional Devices Revenue by Region (2027-2032)
  5. 7.1.4 Global Neurovascular Interventional Devices Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Neurovascular Interventional Devices Revenue (2021-2032)
  8. 7.2.2 North America Neurovascular Interventional Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Neurovascular Interventional Devices Revenue (2021-2032)
  11. 7.3.2 Europe Neurovascular Interventional Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Neurovascular Interventional Devices Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Neurovascular Interventional Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Neurovascular Interventional Devices Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Neurovascular Interventional Devices Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Neurovascular Interventional Devices Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Medtronic PLC
  8. 8.2.1 Medtronic PLC Company Information
  9. 8.2.2 Medtronic PLC Business Overview
  10. 8.2.3 Medtronic PLC Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Medtronic PLC Neurovascular Interventional Devices Product Portfolio
  12. 8.2.5 Medtronic PLC Recent Developments
  13. 8.3 W.L. Gore & Associates
  14. 8.3.1 W.L. Gore & Associates Company Information
  15. 8.3.2 W.L. Gore & Associates Business Overview
  16. 8.3.3 W.L. Gore & Associates Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 W.L. Gore & Associates Neurovascular Interventional Devices Product Portfolio
  18. 8.3.5 W.L. Gore & Associates Recent Developments
  19. 8.4 Terumo Corporation
  20. 8.4.1 Terumo Corporation Company Information
  21. 8.4.2 Terumo Corporation Business Overview
  22. 8.4.3 Terumo Corporation Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Terumo Corporation Neurovascular Interventional Devices Product Portfolio
  24. 8.4.5 Terumo Corporation Recent Developments
  25. 8.5 Stryker Corporation
  26. 8.5.1 Stryker Corporation Company Information
  27. 8.5.2 Stryker Corporation Business Overview
  28. 8.5.3 Stryker Corporation Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Stryker Corporation Neurovascular Interventional Devices Product Portfolio
  30. 8.5.5 Stryker Corporation Recent Developments
  31. 8.6 Penumbra, Inc.
  32. 8.6.1 Penumbra, Inc. Company Information
  33. 8.6.2 Penumbra, Inc. Business Overview
  34. 8.6.3 Penumbra, Inc. Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Penumbra, Inc. Neurovascular Interventional Devices Product Portfolio
  36. 8.6.5 Penumbra, Inc. Recent Developments
  37. 8.7 Microport Scientific Corporation
  38. 8.7.1 Microport Scientific Corporation Company Information
  39. 8.7.2 Microport Scientific Corporation Business Overview
  40. 8.7.3 Microport Scientific Corporation Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Microport Scientific Corporation Neurovascular Interventional Devices Product Portfolio
  42. 8.7.5 Microport Scientific Corporation Recent Developments
  43. 8.8 Merit Medical Systems, Inc.
  44. 8.8.1 Merit Medical Systems, Inc. Company Information
  45. 8.8.2 Merit Medical Systems, Inc. Business Overview
  46. 8.8.3 Merit Medical Systems, Inc. Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merit Medical Systems, Inc. Neurovascular Interventional Devices Product Portfolio
  48. 8.8.5 Merit Medical Systems, Inc. Recent Developments
  49. 8.9 Cardinal Health
  50. 8.9.1 Cardinal Health Company Information
  51. 8.9.2 Cardinal Health Business Overview
  52. 8.9.3 Cardinal Health Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cardinal Health Neurovascular Interventional Devices Product Portfolio
  54. 8.9.5 Cardinal Health Recent Developments
  55. 8.10 Boston Scientific Corporation
  56. 8.10.1 Boston Scientific Corporation Company Information
  57. 8.10.2 Boston Scientific Corporation Business Overview
  58. 8.10.3 Boston Scientific Corporation Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Boston Scientific Corporation Neurovascular Interventional Devices Product Portfolio
  60. 8.10.5 Boston Scientific Corporation Recent Developments
  61. 8.11 Abbott Laboratories
  62. 8.11.1 Abbott Laboratories Company Information
  63. 8.11.2 Abbott Laboratories Business Overview
  64. 8.11.3 Abbott Laboratories Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Abbott Laboratories Neurovascular Interventional Devices Product Portfolio
  66. 8.11.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neurovascular Interventional Devices Value Chain Analysis
  2. 9.1.1 Neurovascular Interventional Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neurovascular Interventional Devices Production Mode & Process
  6. 9.2 Neurovascular Interventional Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neurovascular Interventional Devices Distributors
  9. 9.2.3 Neurovascular Interventional Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst